Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus retinitis.

C G Keith, J La Nauze

    The Medical Journal of Australia
    |January 12, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Cytomegalovirus retinitis in a patient with lymphatic leukemia improved after stopping immunosuppressive therapy. Complete resolution was achieved with lymphocyte transfer factor injection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cataracts, the community and care: are we prepared?

    Clinical & experimental ophthalmology·2000
    Same author

    Intraocular lens power prediction in a vietnamese population. A study to establish a limited set of intraocular lens powers that could be used in a vietnamese population.

    Ophthalmic epidemiology·1999
    Same author

    Extracapsular cataract surgery in Vietnam: a 1 year follow-up study.

    Australian and New Zealand journal of ophthalmology·1998
    Same author

    Modern surgery for global cataract blindness: preliminary considerations.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1998
    Same author

    Low-cost intraocular lenses for cataract patients.

    Lancet (London, England)·1997
    Same author

    Cost-minimization analysis of capsulotomy after ECCE and IOL implantation.

    Ophthalmic epidemiology·1996
    Same journal

    Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

    The Medical journal of Australia·2026
    Same journal

    Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

    The Medical journal of Australia·2026
    Same journal

    Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

    The Medical journal of Australia·2026
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Immunology
    • Hematology

    Background:

    • Cytomegalovirus (CMV) retinitis can occur in immunocompromised individuals.
    • Maintenance immunosuppressive therapy for lymphatic leukemia can increase the risk of opportunistic infections like CMV retinitis.

    Observation:

    • A patient with lymphatic leukemia undergoing maintenance immunosuppressive therapy developed cytomegalovirus retinitis.
    • The retinitis showed signs of improvement upon discontinuation of the immunosuppressive treatment.

    Findings:

    • Cessation of immunosuppressive therapy led to partial improvement of CMV retinitis.
    • Complete resolution of cytomegalovirus retinitis was achieved following an injection of lymphocyte dialysable transfer factor.

    Implications:

    Related Experiment Videos

    • This case highlights the potential for reversing CMV retinitis by adjusting immunosuppressive therapy.
    • Lymphocyte dialysable transfer factor may be a viable therapeutic option for managing CMV retinitis in specific patient populations.
    • Further research is warranted to explore the efficacy and mechanisms of lymphocyte transfer factor in treating viral retinitis.